GLP- 1 Receptor Agonists for the Treatment of Obesity Liraglutide Liraglutide at a high dose of 3 mg daily is approved for long-term weight control in adults and children over the age of 12 with obesity or overweight plus at least one weight-related comorbidity
Strengthens Immune Function With its role in red blood cell production and immune system support, B12 therapy helps the body fight illness and recover faster
Antioxid Redox Signal 9 , 2547 (2007)
Liraglutide (daily injection
Oral Semaglutide delivers the benefits of GLP-1 therapy in a once-daily tablet, helping patients lose weight by reducing appetite, increasing feelings of fullness, and supporting healthier eating habits
Oezer K, Kolibabka M, Gassenhuber J, et al